The global multiple system atrophy therapeutics market is witnessing steady growth, underpinned by technological advancements, rising awareness of neurodegenerative conditions, and increased healthcare investment. According to a recent market analysis, the market was valued at USD 137.3 million in 2023 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.4%, reaching …